82 related articles for article (PubMed ID: 7146070)
21. [Allosteric properties of cholinesterases].
Dolgo-Saburov VB; Mukhamedzhanov EK
Ukr Biokhim Zh; 1972; 44(3):400-5. PubMed ID: 4575748
[No Abstract] [Full Text] [Related]
22. Five oximes (K-27, K-33, K-48, BI-6 and methoxime) in comparison with pralidoxime: in vitro reactivation of red blood cell acetylcholinesterase inhibited by paraoxon.
Petroianu GA; Arafat K; Kuca K; Kassa J
J Appl Toxicol; 2006; 26(1):64-71. PubMed ID: 16193529
[TBL] [Abstract][Full Text] [Related]
23. Synthesis of the novel series of bispyridinium compounds bearing (E)-but-2-ene linker and evaluation of their reactivation activity against chlorpyrifos-inhibited acetylcholinesterase.
Musilek K; Kuca K; Jun D; Dohnal V; Dolezal M
Bioorg Med Chem Lett; 2006 Feb; 16(3):622-7. PubMed ID: 16288867
[TBL] [Abstract][Full Text] [Related]
24. Abnormal cholinesterase activity: understanding and interpretation.
Jokanović M; Maksimović M
Eur J Clin Chem Clin Biochem; 1997 Jan; 35(1):11-6. PubMed ID: 9156559
[TBL] [Abstract][Full Text] [Related]
25. Effect of five acetylcholinesterase reactivators on tabun-intoxicated rats: induction of oxidative stress versus reactivation efficacy.
Pohanka M; Karasova JZ; Musilek K; Kuca K; Kassa J
J Appl Toxicol; 2009 Aug; 29(6):483-8. PubMed ID: 19338015
[TBL] [Abstract][Full Text] [Related]
26. In vitro reactivation potency of some acetylcholinesterase reactivators against sarin- and cyclosarin-induced inhibitions.
Kuca K; Cabal J; Jun D; Kassa J; Bartosová L; Kunesová G
J Appl Toxicol; 2005; 25(4):296-300. PubMed ID: 16025528
[TBL] [Abstract][Full Text] [Related]
27. Nucleophilicity of some reactivators of phosphorylated acetylcholinesterase.
Ashani Y; Cohen S
J Med Chem; 1971 Jul; 14(17):621-6. PubMed ID: 5164452
[No Abstract] [Full Text] [Related]
28. Potency of five structurally different acetylcholinesterase reactivators to reactivate human brain cholinesterases inhibited by cyclosarin.
Kuca K; Cabal J; Jun D; Hrabinova M
Clin Toxicol (Phila); 2007; 45(5):512-5. PubMed ID: 17503257
[TBL] [Abstract][Full Text] [Related]
29. Bisquaternary oximes as reactivators of tabun-inhibited human brain cholinesterases: an in vitro study.
Kuca K; Jun D; Cabal J; Musilova L
Basic Clin Pharmacol Toxicol; 2007 Jul; 101(1):25-8. PubMed ID: 17577312
[TBL] [Abstract][Full Text] [Related]
30. Interaction of pentylsarin analogues with human acetylcholinesterase: a kinetic study.
Worek F; Herkert NM; Koller M; Aurbek N; Thiermann H
Toxicol Lett; 2009 Jun; 187(2):119-23. PubMed ID: 19429253
[TBL] [Abstract][Full Text] [Related]
31. Metoclopramide protection of cholinesterase from paraoxon inhibition.
Petroianu GA; Hasan MY; Kosanovic M; Vijayasarathy C; Saleh AM
Vet Hum Toxicol; 2003 Oct; 45(5):251-3. PubMed ID: 14513894
[TBL] [Abstract][Full Text] [Related]
32. New oxime reactivators connected with CH2O(CH2)nOCH2 linker and their reactivation potency for organophosphorus agents-inhibited acetylcholinesterase.
Yang GY; Oh KA; Park NJ; Jung YS
Bioorg Med Chem; 2007 Dec; 15(24):7704-10. PubMed ID: 17869525
[TBL] [Abstract][Full Text] [Related]
33. Structural bioinformatics and QSAR analysis applied to the acetylcholinesterase and bispyridinium aldoximes.
Mager PP; Weber A
Drug Des Discov; 2003; 18(4):127-50. PubMed ID: 15553925
[TBL] [Abstract][Full Text] [Related]
34. In vitro reactivation of tabun-inhibited acetylcholinesterase using new oximes--K027, K005, K033 and K048.
Kuca K; Cabal J
Cent Eur J Public Health; 2004 Mar; 12 Suppl():S59-61. PubMed ID: 15141981
[TBL] [Abstract][Full Text] [Related]
35. Reversible inhibition of acetylcholinesterase by carbamates or huperzine A increases residual activity of the enzyme upon soman challenge.
Eckert S; Eyer P; Worek F
Toxicology; 2007 Apr; 233(1-3):180-6. PubMed ID: 17097792
[TBL] [Abstract][Full Text] [Related]
36. Enzyme-kinetic investigation of different sarin analogues reacting with human acetylcholinesterase and butyrylcholinesterase.
Bartling A; Worek F; Szinicz L; Thiermann H
Toxicology; 2007 Apr; 233(1-3):166-72. PubMed ID: 16904809
[TBL] [Abstract][Full Text] [Related]
37. Fluorinated pyridinium oximes as potential reactivators for acetylcholinesterases inhibited by paraoxon organophosphorus agent.
Jeong HC; Park NJ; Chae CH; Musilek K; Kassa J; Kuca K; Jung YS
Bioorg Med Chem; 2009 Sep; 17(17):6213-7. PubMed ID: 19665386
[TBL] [Abstract][Full Text] [Related]
38. Interactions of oxime reactivators with diethylphosphoryl adducts of human acetylcholinesterase and its mutant derivatives.
Grosfeld H; Barak D; Ordentlich A; Velan B; Shafferman A
Mol Pharmacol; 1996 Sep; 50(3):639-49. PubMed ID: 8794905
[TBL] [Abstract][Full Text] [Related]
39. In vitro inhibitory effect of aflatoxin B1 on acetylcholinesterase activity in mouse brain.
Cometa MF; Lorenzini P; Fortuna S; Volpe MT; Meneguz A; Palmery M
Toxicology; 2005 Jan; 206(1):125-35. PubMed ID: 15590113
[TBL] [Abstract][Full Text] [Related]
40. Kinetic analysis of the protection afforded by reversible inhibitors against irreversible inhibition of acetylcholinesterase by highly toxic organophosphorus compounds.
Eckert S; Eyer P; Mückter H; Worek F
Biochem Pharmacol; 2006 Jul; 72(3):344-57. PubMed ID: 16780806
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
